AMPLATZER
Device
Abbott Laboratories
Total Payments
$2.3M
Transactions
6,981
Doctors
2,502
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $496,464 | 796 | 411 |
| 2023 | $402,513 | 1,045 | 495 |
| 2022 | $1.4M | 5,140 | 1,910 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $934,855 | 378 | 41.4% |
| Travel and Lodging | $472,706 | 1,196 | 20.9% |
| Unspecified | $407,263 | 200 | 18.0% |
| Food and Beverage | $306,488 | 5,081 | 13.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $92,780 | 40 | 4.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $43,750 | 74 | 1.9% |
| Space rental or facility fees (teaching hospital only) | $2,833 | 12 | 0.1% |
Payments by Type
General
$1.9M
6,781 transactions
Research
$407,263
200 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PARADIGM PARAvalvular Leak Closure With the Amplatzer Valvular Plug occluDer for Interventional Transcatheter Closure for PVL With Surgical bioloGical and Mechanical Heart Valve | Abbott Laboratories | $177,201 | 0 |
| PARAvalvular leak closure with the Amplatzer valvular plug occluDer for Interventional transcatheter closure for chronic PVL with surgical bioloGical and Mechanical heart valve (Paradigm-PVL) | Abbott Laboratories | $92,217 | 0 |
| The AMPLATZER Post-Infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study | Abbott Laboratories | $66,492 | 0 |
| AMPLATZER Duct Occluder II Additional Sizes (ADO II AS) Clinical Study | Abbott Laboratories | $27,151 | 0 |
| Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study (VPA) | Abbott Laboratories | $25,688 | 0 |
| Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study | Abbott Laboratories | $13,199 | 0 |
| AMPLATZER Duct Occluder II Additional Sizes (ADO II AS) | Abbott Laboratories | $3,950 | 0 |
| AMPLATZER Duct Occluder II Additional Sizes Clinical Study | Abbott Laboratories | $1,125 | 0 |
| PARADIGM | Abbott Laboratories | $240.00 | 0 |
Ad
Manufacturing Companies
- Abbott Laboratories $2.3M
Product Information
- Type Device
- Total Payments $2.3M
- Total Doctors 2,502
- Transactions 6,981
About AMPLATZER
AMPLATZER is a device associated with $2.3M in payments to 2,502 healthcare providers, recorded across 6,981 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2022 to 2024. In 2024, $496,464 was paid across 796 transactions to 411 doctors.
The most common payment nature for AMPLATZER is "Consulting Fee" ($934,855, 41.4% of total).
AMPLATZER is associated with 9 research studies, including "PARADIGM PARAvalvular Leak Closure With the Amplatzer Valvular Plug occluDer for Interventional Transcatheter Closure for PVL With Surgical bioloGical and Mechanical Heart Valve" ($177,201).